Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Jul 27, 2024; 16(7): 2270-2280
Published online Jul 27, 2024. doi: 10.4240/wjgs.v16.i7.2270
Published online Jul 27, 2024. doi: 10.4240/wjgs.v16.i7.2270
Table 4 Comparison of colonoscopy load for detecting advanced tumors
| Screening phase | Advanced tumors (n, 95%CI) | ||
| Colonoscopy group | FIT group | Graded screening group | |
| Baseline screening | |||
| Overall | 15.4 (12.8-18.5) | 9.1 (7.5-11.1) | 10.3 (8.8-12.2) |
| Male | 10.7 (8.5-13.5) | 6.5 (5.2-8.3) | 8.0 (6.7-9.5) |
| Female | 22.9 (17.0-30.9) | 14.7 (10.4-21.1) | 22.4 (14.9-34.0) |
| Baseline screening + 1st follow-up screening | |||
| Overall | 15.4 (12.8-18.5) | 8.3 (7.1-9.7) | 10.5 (9.0-12.2) |
| Male | 10.7 (8.5-13.5) | 6.2 (5.1-7.5) | 8.2 (6.9-9.8) |
| Female | 22.9 (17.0-30.9) | 12.5 (9.4-16.7) | 18.6 (13.4-26.1) |
| Baseline screening + 1st follow-up screening + 2nd follow-up screening | |||
| Overall | 15.4 (12.8-18.5) | 7.8 (6.8-9.0) | 10.2 (8.9-11.8) |
| Male | 10.7 (8.5-13.5) | 5.9 (5.0-7.0) | 8.3 (7.1-9.8) |
| Female | 22.9 (17.0-30.9) | 11.4 (8.9-14.5) | 15.3 (11.8-20.1) |
- Citation: Xu M, Yang JY, Meng T. Effectiveness of colonoscopy, immune fecal occult blood testing, and risk-graded screening strategies in colorectal cancer screening. World J Gastrointest Surg 2024; 16(7): 2270-2280
- URL: https://www.wjgnet.com/1948-9366/full/v16/i7/2270.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i7.2270